Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Other financing activities (as filed) (2013 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Other financing activities (as filed) of -$661,000 in fiscal Q2 2027 (quarter ended Sep 30, 2026).

Analysis

Grace Therapeutics (GRCE) Other financing activities (as filed) (2013 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Other financing activities (as filed) of -$327,000.

  • Across earlier fiscal years, Other financing activities (as filed) came in at -$967,000 in FY2025 and -$162,000 in FY2024.
  • The fiscal Q2 2027 figure is the highest quarterly Other financing activities (as filed) since fiscal Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -661,000.00
Jun 30, 2025 -327,000.00
Mar 31, 2025 -967,000.00
Sep 30, 2020 -1,000.00
Jun 30, 2020 -140,000.00
Mar 31, 2020 74,000.00
Dec 31, 2019 -31,000.00
Sep 30, 2019 -36,000.00
Mar 31, 2019 -134,000.00
Aug 31, 2013 -29,000.00
API Access

Grace Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=GRCE&period=max&api_key=YOUR_API_KEY